Phase I dose escalation and pharmacokinetics clinical trial of mitoxantrone hydrochloride liposome in children with relapsed and refractory solid tumors
机构：[1]Sun Yat-sen University Cancer Center, Guangzhou, China[2]Sichuan Cancer Hospital, Chengdu, China四川省肿瘤医院[3]Wuhan Children's Hospital, Wuhan, China[4]The Fifth Affiliated Hospital, Guangzhou, China[5]Yuexiu District, Guangzhou, China
第一作者机构：[1]Sun Yat-sen University Cancer Center, Guangzhou, China
推荐引用方式(GB/T 7714)：
Huang Junting,Ji Mingqing,Li Hui,et al.Phase I dose escalation and pharmacokinetics clinical trial of mitoxantrone hydrochloride liposome in children with relapsed and refractory solid tumors[J].JOURNAL OF CLINICAL ONCOLOGY.2024,42(16):
APA：
Huang, Junting,Ji, Mingqing,Li, Hui,Wu, Yanpeng,Cai, Ruiqing...&Zhang, Yizhuo.(2024).Phase I dose escalation and pharmacokinetics clinical trial of mitoxantrone hydrochloride liposome in children with relapsed and refractory solid tumors.JOURNAL OF CLINICAL ONCOLOGY,42,(16)
MLA：
Huang, Junting,et al."Phase I dose escalation and pharmacokinetics clinical trial of mitoxantrone hydrochloride liposome in children with relapsed and refractory solid tumors".JOURNAL OF CLINICAL ONCOLOGY 42..16(2024)
医学